The University of Melbourne, Australia

Zalihe Hakki

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: The University of Melbourne. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zalihe Hakki. Retrieved from https://idiyas.com/inventor/zalihe-hakki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zalihe Hakki: Innovator in Respiratory Disease Treatment

Introduction

Zalihe Hakki is a notable inventor based at The University of Melbourne, Australia. He has made significant contributions to the field of respiratory disease treatment through his innovative research and development of new compounds.

Latest Patents

Zalihe Hakki holds a patent for "Compounds for the treatment of respiratory diseases." This invention relates to new compounds that are useful in the prevention or treatment of respiratory diseases, such as asthma, acute and chronic inflammatory conditions, and fibrotic diseases. The patent also covers the preparation of these compounds and their use in treating or preventing various respiratory conditions.

Career Highlights

Throughout his career, Zalihe Hakki has focused on advancing medical treatments for respiratory diseases. His work has been instrumental in developing effective solutions that address the complexities of these conditions.

Collaborations

Zalihe has collaborated with esteemed colleagues, including Alastair George Stewart and Spencer John Williams, to further enhance the impact of his research.

Conclusion

Zalihe Hakki's contributions to the treatment of respiratory diseases through his innovative compounds highlight his dedication to improving health outcomes. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…